Objective: Two methods using exercise and body cooling could influence the well-being of patients with multiple sclerosis (PwMS). The aim of this study was to determine whether wearing a cooling vest during a physical training program could increase the cognitive and physical capacities and quality of life in PwMS. Methods: Eighteen PwMS (49.6 ± 8 years; Expanded Disability Status Score 5.0 ± 1.0) were randomly assigned to a cooling or control group. PwMS underwent a 7-week physical training program. In the cooling group, PwMS wore a cooling vest during each training session, whereas in the control group, PwMS wore a cotton T-shirt. Before and after the training program, both groups completed the Isaacs Set Test (IST), Trail Making Test A-B (TMT A-B), SEP-59, Multidimensional Fatigue Inventory and performed a 6-minute walk test (6MWT). Results: The cooling group showed significantly (p < 0.05) improved performance for IST, TMT A and 6MWT. Their emotional well-being and cognitive functions investigated in SEP-59 were significantly (p < 0.05) improved, and general and physical fatigue significantly (p < 0.05) decreased. Conclusions: This physical training program combined with a cooling strategy could have a significant positive influence on both cognitive and physical performances, perceived fatigue and emotional well-being in heat-sensitive PwMS.

Cattaneo D, De Nuzzo C, Fascia T, Macalli M, Pisoni I, Cardini R: Risks of falls in subjects with multiple sclerosis. Arch Phys Med Rehabil 2002;83:864-867.
Chiaravalloti ND, DeLuca J: Cognitive impairment in multiple sclerosis. Lancet Neurology 2008;7:1139-1151.
Feys P, Helsen W, Liu X, et al: Effects of peripheral cooling on intention tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:373-379.
Lysandropoulos AP, Havrdova E: Hidden factors influencing quality of life in patients with multiple sclerosis. Eur J Neurol 2015;22:28-33.
Guthrie TC, Nelson DA: Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci 1995;129:1-8.
Schwid SR, Petrie MD, Murray R, et al: A randomized controlled study of the acute and chronic effects of cooling therapy for MS. Neurology 2003;60:1955-1960.
Bouzigon R, Grappe F, Ravier G, Dugué B: Whole- and partial-body cryostimulation/cryotherapy: current technologies and practical applications. J Therm Biol 2016;61:67-81.
Miller E, Kostka J, Wlodarczyk T, Dugué B: Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study. Acta Neurol Scand 2016;134:420-426.
Kinnman J, Andersson T, Andersson G: Effect of cooling suit treatment in patients with multiple sclerosis evaluated by evoked potentials. Scand J Rehabil Med 2000;32:16-19.
Nilsagård Y, Denison E, Gunnarsson L: Evaluation of a single session with cooling garment for persons with multiple sclerosis: a randomized trial. Disabil Rehabil Assist Technol 2006;1:225-233.
Capello E, Gardella M, Leandri M: Lowering body temperature with a cooling suit as symptomatic treatment for thermosensitive multiple sclerosis patients. Ital J Neurol Sci 1995;16:533-539.
Gossmann A, Eling P, Kastrup A, Hildebrandt H: No effect of cooling on cognitive fatigue, vigilance and autonomic functioning in multiple sclerosis. J Mult Scler 2014;1:2-7.
Magnin E, Sagawa Y Jr, Chamard L, Berger E, Moulin T, Decavel P: Verbal fluencies and Fampridine treatment in multiple sclerosis. Eur Neurol 2015;74:243-250.
Motl RW, Sandroff BM: Benefits of exercise training in multiple sclerosis. Curr Neurol Neurosci Rep 2015;15:62.
McDonald WI, Compston A, Edan G, et al: Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
Faucher M, Rouvillois J, Charry B: Questionnaire on the Influence of Changes in Outdoor Temperature on the Daily Activity of Patients with Multiple Sclerosis. Rehabilitation Center of Gassies, UGECAM Aquitaine, France. Unpublished Document.
Altman DG, Schultz KF, Moher D, et al: The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-694.
Gonzales B, Guillot R, Hagin V, Monnier-Benoit P, Placet V, Groslambert A: Self-paced cycling performance and recovery under a hot and highly humid environment after cooling. J Sports Med Phys Fitness 2014;54:43-52.
Borg G: Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970;2:92-98.
Isaacs B, Kennie AT: The Set Test as an aid to the detection of dementia in old people. Br J Psychiatry 1973;123:467-470.
Reitan R: Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315-325.
Vernay D, Gerbaud L, Biolay S, et al: Qualité de vie et sclérose en plaques: validation de la version francophone d'un auto-questionnaire, le SEP-59. Rev Neurol 2000;156:247-263.
Goldman MD, Marrie RA, Cohen JA: Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler 2008;14:383-390.
Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erlbaum, 1988.
DeLuca J, Chelune GJ, Tulsky DS, Lengenfelder J, Chiaravalloti ND: Is speed of processing or working memory the primary information processing deficit in multiple sclerosis? J Clin Exp Neuropsychol 2004;26:550-562.
Crawford JR, Henry JD: Assessment of executive deficits; in Halligan PW, Wade N (eds): The Effectiveness of Rehabilitation for Cognitive Deficits. London, Oxford University Press, 2005, pp 233-246.
Côté I, Trojan DA, Kaminska M: Impact of sleep disorder treatment on fatigue in multiple sclerosis. Mult Scler J 2012;19:480-489.
Pearson M, Dieberg G, Smart N: Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: a meta-analysis. Arch Phys Med Rehabil 2015;96:1339-1348.
Kerdoncuff V, Durufle A, Le Tallec H, et al: Multiple sclerosis and physical activities. Ann Readapt Med Phys 2006;49:32-36.
D'haeseleer M, Hostenbach S, Peeters I, et al: Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis? J Cereb Blood Flow Metab 2015;35:1406-1410.
Bain AR, Nybo L, Ainslie PN: Cerebral vascular control and metabolism in heat stress. Compr Physiol 2015;5:1345-1380.
Heinonen I, Kalliokoski KK, Hannukainen JC, Duncker DJ, Nuutila P, Knuuti J: Organ-specific physiological responses to acute physical exercise and long-term training in humans. Physiology (Bethesda) 2014;29:421-436.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.